Beyond Air, Inc. (AITB) Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on June 28, 2019, by Beyond Air, Inc. (formerly AIT Therapeutics, Inc.), an emerging growth company incorporated in Delaware. The report covers events occurring on June 25, 2019, and June 26, 2019.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance changes and the correction of a prior press release rather than the disclosure of new financial statement data.
Material Changes
- Corporate Name Change: Effective June 26, 2019, the Company changed its name from "AIT Therapeutics, Inc." to "Beyond Air, Inc." via a Certificate of Amendment filed with the State of Delaware.
- Trading Symbol Update: The Company expects its ticker symbol to change from "AITB" to "XAIR" on or about July 15, 2019.
- Press Release Correction: The Company issued a press release on June 28, 2019, to correct and replace information contained in a press release issued on June 25, 2019. The corrected release is attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future operations, or a discussion of risks and contingencies beyond the standard legal disclaimers. The name change is explicitly stated not to affect the rights of security holders.
Key Facts for Investor Verification
- Verify the content of the corrected press release (Exhibit 99.1) to understand the specific information amended from the June 25, 2019 announcement.
- Confirm the effective date of the ticker symbol change to "XAIR" on the Nasdaq Stock Market.
- Review the Company's Annual Report on Form 10-K (filed June 28, 2019) for the most recent audited financial data, as this 8-K does not contain financial metrics.